IL44619A - Mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases and process for producing same - Google Patents
Mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases and process for producing sameInfo
- Publication number
- IL44619A IL44619A IL44619A IL4461974A IL44619A IL 44619 A IL44619 A IL 44619A IL 44619 A IL44619 A IL 44619A IL 4461974 A IL4461974 A IL 4461974A IL 44619 A IL44619 A IL 44619A
- Authority
- IL
- Israel
- Prior art keywords
- base
- mixed salt
- solution
- process according
- mixed
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims description 43
- 238000000034 method Methods 0.000 title claims description 20
- 229910052751 metal Inorganic materials 0.000 title claims description 14
- 239000002184 metal Substances 0.000 title claims description 14
- 150000007530 organic bases Chemical class 0.000 title claims description 8
- 102000002068 Glycopeptides Human genes 0.000 title description 5
- 108010015899 Glycopeptides Proteins 0.000 title description 5
- 150000002148 esters Chemical class 0.000 title description 3
- 150000002739 metals Chemical class 0.000 title description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- 125000000129 anionic group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000002048 spasmolytic effect Effects 0.000 claims description 5
- 239000000812 cholinergic antagonist Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 150000002892 organic cations Chemical class 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 239000002585 base Substances 0.000 claims 9
- 239000002904 solvent Substances 0.000 claims 5
- 239000003513 alkali Substances 0.000 claims 3
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 1
- 229920000447 polyanionic polymer Polymers 0.000 claims 1
- 108010024093 sulglicotide Proteins 0.000 claims 1
- 239000000243 solution Substances 0.000 description 22
- 239000011347 resin Substances 0.000 description 11
- 229920005989 resin Polymers 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000011282 treatment Methods 0.000 description 6
- 239000003643 water by type Substances 0.000 description 6
- 238000005406 washing Methods 0.000 description 5
- 241000282326 Felis catus Species 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 150000002402 hexoses Chemical class 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000294754 Macroptilium atropurpureum Species 0.000 description 2
- 229940118324 anisotropine Drugs 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- XGGHHHBGPSNXFE-ZSHCYNCHSA-N chembl1186610 Chemical compound C1[C@H](OC(=O)C(CCC)CCC)C[C@@H]2CC[C@H]1[N+]2(C)C XGGHHHBGPSNXFE-ZSHCYNCHSA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- ZGKIYLYSHXFWES-UHFFFAOYSA-N pentanoic acid;hydrobromide Chemical compound Br.CCCCC(O)=O ZGKIYLYSHXFWES-UHFFFAOYSA-N 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 description 1
- 101150043246 GAST gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 description 1
- 235000011096 Papaver Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- -1 glycopeptide sodium salt Chemical class 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/32—Extraction; Separation; Purification by precipitation as complexes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22212/73A IT1061352B (it) | 1973-03-27 | 1973-03-27 | Sali misti di esteri polisolforici di glicopeptidi naturali con metalli e con basi organiche e procedimento per la loro preparazione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL44619A0 IL44619A0 (en) | 1974-09-10 |
| IL44619A true IL44619A (en) | 1977-03-31 |
Family
ID=11193113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL44618A IL44618A (en) | 1973-03-27 | 1974-04-12 | Pharmaceutical compositions comprising mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases |
| IL44619A IL44619A (en) | 1973-03-27 | 1974-04-12 | Mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases and process for producing same |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL44618A IL44618A (en) | 1973-03-27 | 1974-04-12 | Pharmaceutical compositions comprising mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US3900458A (xx) |
| JP (1) | JPS5029727A (xx) |
| AR (1) | AR204623A1 (xx) |
| AT (1) | AT347608B (xx) |
| AU (1) | AU476679B2 (xx) |
| BE (2) | BE812904A (xx) |
| CA (1) | CA1023352A (xx) |
| CH (1) | CH591244A5 (xx) |
| DE (2) | DE2413803A1 (xx) |
| ES (1) | ES424636A1 (xx) |
| FR (2) | FR2223012B1 (xx) |
| GB (1) | GB1410296A (xx) |
| IE (1) | IE39191B1 (xx) |
| IL (2) | IL44618A (xx) |
| IT (1) | IT1061352B (xx) |
| NL (1) | NL7404167A (xx) |
| NO (1) | NO145272C (xx) |
| PH (1) | PH11790A (xx) |
| PL (1) | PL92521B1 (xx) |
| RO (1) | RO65567A (xx) |
| SE (1) | SE416131B (xx) |
| YU (1) | YU83574A (xx) |
| ZA (2) | ZA741977B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1190133B (it) * | 1986-06-19 | 1988-02-10 | Chiesi Farma Spa | Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| JPS63162561A (ja) * | 1986-12-25 | 1988-07-06 | 株式会社吉兆総合商事 | 無塩素防水剤含有セメント組成物 |
| IT1215332B (it) * | 1987-01-12 | 1990-02-08 | Crinos Industria Farmaco | Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica |
| KR101819709B1 (ko) * | 2017-01-13 | 2018-01-17 | (주)아이엠디팜 | 설글리코타이드 또는 이의 약학적으로 허용가능한 염을 포함하는 안구건조증의 예방 또는 치료용 약학 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3174899A (en) * | 1960-12-30 | 1965-03-23 | Ciba Geigy Corp | Composition for the management of post antibiotic enteritis |
| BE633486A (xx) * | 1962-06-18 | |||
| US3441646A (en) * | 1965-01-22 | 1969-04-29 | Commercial Solvents Corp | Bacitracin metal methane sulfinate and process for producing |
| IT1056709B (it) * | 1967-02-23 | 1982-02-20 | Prino G | Derivati solfonati d un glicopepti de esteratto da organi animali utili come farmaci e processo per la loro preparazione |
| US3476738A (en) * | 1967-12-04 | 1969-11-04 | Upjohn Co | Pentakis(n-(sulfomethyl))circulin and salts thereof |
| US3607650A (en) * | 1970-05-15 | 1971-09-21 | Prephar | Process for the enzymatic extraction and purification of a glycopeptide obtained from animal organs,useful as a drug |
-
1973
- 1973-03-27 IT IT22212/73A patent/IT1061352B/it active
-
1974
- 1974-01-01 AR AR252983A patent/AR204623A1/es active
- 1974-03-13 AT AT208174A patent/AT347608B/de not_active IP Right Cessation
- 1974-03-22 US US453765A patent/US3900458A/en not_active Expired - Lifetime
- 1974-03-22 DE DE2413803A patent/DE2413803A1/de not_active Withdrawn
- 1974-03-22 FR FR7409914A patent/FR2223012B1/fr not_active Expired
- 1974-03-22 US US453764A patent/US3926921A/en not_active Expired - Lifetime
- 1974-03-22 DE DE2413802A patent/DE2413802C2/de not_active Expired
- 1974-03-25 SE SE7404014A patent/SE416131B/xx unknown
- 1974-03-25 FR FR7410131A patent/FR2223015B1/fr not_active Expired
- 1974-03-25 CH CH414674A patent/CH591244A5/xx not_active IP Right Cessation
- 1974-03-26 YU YU00835/74A patent/YU83574A/xx unknown
- 1974-03-26 PH PH15659A patent/PH11790A/en unknown
- 1974-03-26 CA CA195,978A patent/CA1023352A/en not_active Expired
- 1974-03-26 NO NO741079A patent/NO145272C/no unknown
- 1974-03-26 ES ES424636A patent/ES424636A1/es not_active Expired
- 1974-03-26 AU AU67165/74A patent/AU476679B2/en not_active Expired
- 1974-03-26 RO RO7478188A patent/RO65567A/ro unknown
- 1974-03-27 PL PL1974169863A patent/PL92521B1/pl unknown
- 1974-03-27 BE BE142510A patent/BE812904A/xx not_active IP Right Cessation
- 1974-03-27 GB GB1361174A patent/GB1410296A/en not_active Expired
- 1974-03-27 BE BE142509A patent/BE812903A/xx not_active IP Right Cessation
- 1974-03-27 ZA ZA00741977A patent/ZA741977B/xx unknown
- 1974-03-27 JP JP49033595A patent/JPS5029727A/ja active Pending
- 1974-03-27 ZA ZA00741976A patent/ZA741976B/xx unknown
- 1974-03-27 NL NL7404167A patent/NL7404167A/xx unknown
- 1974-03-27 IE IE672/74A patent/IE39191B1/xx unknown
- 1974-04-12 IL IL44618A patent/IL44618A/en unknown
- 1974-04-12 IL IL44619A patent/IL44619A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0044050B1 (de) | Verfahren zur Herstellung von Eisen (III)-Hydroxid-Dextran-Komplexen und diese enthaltende pharmazeutische sterile Lösung | |
| EP0119420A1 (de) | In Wasser schnell und stark quellende Cyclodextrinpolymere, Verfahren zu deren Herstellung und deren Verwendung als Desintegrationsmittel für die Tablettenherstellung | |
| DE69102490T2 (de) | Verfahren zur Herstellung von Pyrokatechinkomplexen. | |
| IL44619A (en) | Mixed salts of polysulfuric esters of naturally occurring glycopeptides with metals and organic bases and process for producing same | |
| EP0162426A2 (de) | Verfahren zur Gewinnung einer Faktor XIII-Präparation sowie ihre Verwendung | |
| US4238518A (en) | Process for the preparation of a stable Beta vulgaris extract | |
| US3110711A (en) | Process of producing two escin isomers from horse chestnut extracts, and products | |
| DE2924566C2 (de) | Eisen(III)-Chondroitinsulfat-Komplex, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung | |
| O'Meara et al. | 909. Alkaline degradation of polysaccharides. Part V. Periodate oxycellulose | |
| DE938502C (de) | Verfahren zur Herstellung einer kolloidalen Eisenzubereitung | |
| DE2721766C2 (xx) | ||
| DE2241076C3 (de) | Tetracyclinkomplex und dessen Salze, Verfahren zu dessen Herstellung und diesen Komplex enthaltende pahrmazeutische Zusammensetzungen | |
| DE2652272B1 (de) | Verfahren zur Herstellung von Heparin | |
| DE2800943C2 (de) | Verwendung von Darm-Salzlake zur Gewinnung von reinem Heparin | |
| DE2159923A1 (de) | Verfahren zur gewinnung von stoffen mit insulinaehnlicher wirkung aus pflanzen und diese stoffe enthaltende arzneipraeparate | |
| DE2151054A1 (de) | Neue chemische Verbindungen aus Alkaloiden der Chinarinde und Alkan-Sultonen sowie Verfahren zur Herstellung derselben | |
| DE2042324A1 (xx) | ||
| DE665793C (de) | Verfahren zur Herstellung von ª‰-(p-Oxyphenyl)-isopropylmethylamin | |
| AT222807B (de) | Verfahren zur Herstellung eines therapeutisch wirksamen Produktes | |
| CH370194A (de) | Verfahren zur Herstellung von therapeutisch verwendbaren Eisenpräparaten | |
| DE2430463C2 (de) | Verfahren zur Herstellung eines angereicherten Trockenextraktes aus Pflanzen der Gattung Fumaria | |
| DE806994C (de) | Verfahren zur Herstellung eines blutgerinnungshemmenden Mittels | |
| DE373285C (de) | Verfahren zur Herstellung einer 2-Phenylchinolindicarbonsaeure | |
| DE964412C (de) | Verfahren zur Herstellung von Veresterungsprodukten der ª‡, ª‡'-Dimercaptobernsteinsaeure mit Monosacchariden | |
| CH236759A (de) | Verfahren zur Herstellung eines Lactons der Cyclopentanopolyhydrophenanthren-Reihe. |